Eagle Pharmaceuticals, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Eagle Pharmaceuticals, Inc. payments for repurchase of common stock for the quarter ending 2023-06-30 was $0.00.
- Eagle Pharmaceuticals, Inc. payments for repurchase of common stock for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. payments for repurchase of common stock for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. payments for repurchase of common stock for the quarter ending 2022-09-30 was $9.95M, a 20.31% increase year-over-year.
- Eagle Pharmaceuticals, Inc. payments for repurchase of common stock for fiscal 2022 was $18.00M, a 15.13% decline from fiscal 2021.
- Eagle Pharmaceuticals, Inc. payments for repurchase of common stock for fiscal 2021 was $21.21M, a 39.39% decline from fiscal 2020.
- Eagle Pharmaceuticals, Inc. payments for repurchase of common stock for fiscal 2020 was $35.00M, a 94.86% increase from fiscal 2019.
- Eagle Pharmaceuticals, Inc. payments for repurchase of common stock for fiscal 2019 was $17.96M, a 75.43% decline from fiscal 2018.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-08-09 | $9.95M derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $9.95M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $18.00M 10-K · filed 2023-03-23 |
| 2022-09-30 | $9.95M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-09 | $26.65M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-08-09 | $24.97M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $8.05M 10-Q · filed 2023-05-09 | $27.83M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $8.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $21.21M 10-K · filed 2023-03-23 |
| 2021-09-30 | $8.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $19.57M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $34.30M derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $1.43M 10-Q · filed 2022-05-09 | $35.43M derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $35.00M 10-K · filed 2023-03-23 |
| 2020-09-30 | $23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $30.96M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $7.96M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $999.00K 10-Q · filed 2021-05-10 | $18.96M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $17.96M 10-K · filed 2022-03-08 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $65.48M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $77.59M derived: sum of 4 quarters · filed 2021-03-05 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 | $66.10M derived: sum of 4 quarters · filed 2021-03-05 |
| 2018-12-31 | $50.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $73.11M 10-K · filed 2021-03-05 |
| 2018-09-30 | $12.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $27.63M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $29.00M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $7.00M 10-Q · filed 2019-05-07 | $37.14M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $43.79M 10-K · filed 2020-03-02 |
| 2017-09-30 | $13.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $59.30M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $11.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $62.31M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $13.65M 10-Q · filed 2018-05-10 | $50.66M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $20.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $37.00M 10-K · filed 2019-02-28 |
| 2016-09-30 | $16.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $16.50M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-08 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $0.00 10-K · filed 2018-02-26 |
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 | |
| 2014-09-30 | $0.00 10-K · filed 2017-03-15 |